Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic State
Definition
Non-ketotic hyperglycaemic syndrome
Defined as extreme elevation in serum glucose (BSL >33.3) + hyperosmolality (>320mmol/kg) and
absence of ketoacidosis (pH >7.3 + HCO3 >15)
May be the first presentation of type 2 diabetes
Can be a mixed picture with DKA
Pathophysiology
High insulin suppresses lipolysis and ketogenesis but does not regulate blood gluoce production
and utilisation
Hyperosmolality inhibits lipolysis, insulin secretion and glucose uptake
Hypernatraemia + hyperglycaemia + inadequate water intake hypovolaemic state
Adrenaline insulin resistance, decreased insulin production/secretion, increased lipolysis
Risk factors
Non-modifibale
o Age >65 (70 onwards – high mortality risk)
o Endocrine: Cushing’s syndrome, hyperthyroidism, acromegaly
Modifiable
o Poorly controlled diabetes (inadequate insulin/oral antiglycaemic therapy)
o Acute illness in diabetic patient
o Infections
o Post-operative risk
o Precipitating medications (corticosteroids, thiazides, beta-blockers, didanosine)
Investigations
Symptomatic hyperglycaemia (polyuria, polydipsia, abdominal pain, acidotic breath, volume
depletion, altered mental state) should prompt immediate investigation
o Plasma glucose
o Urine ketones
Bedside
o Urine ketones – negative/low
o Urinalysis – positive for gluclose, negative for ketones
o ECG – hyperkalaemia/hypokalaemia
o Look for cause – urine/sputum culture (infection)
Bloods
o ABG - acidosis
o FBE – leucocytosis present in hyperglycaemic crisis
o Blood ketones – negative/low
o Serum urea and creatinine (UECr) – elevated (volume depletion)
o Serum sodium – varied
o Serum potassium – high
o Serum CMP – low
o Serum osmolality - >320mmol/kg
o Look for cause – troponins (MI), blood culture (infection)
Imaging
o Look for cause – CXR (pneumonia)
Prevention
Primary prevention
o Contact diabetes care team/GP quickly when symptomatic or high blood sugars on
glucometer
o Educate on proper insulin and medication use + carbohydrate diet when nauseated
o Educate on frequent blood sugar monitoring
o Eliminate drugs that can precipitate hyperglycaemia
Acute management
Fluid replacement therapy – to reduce DIC
IV insulin – slow infusion with short-acting insulin
o When serum potassium concentration > 3.5mmol/L
Potassium replacement
Phosphate replacement
SPIDER
o S: Saline 10-20ml/kg bolus
o P: Potassium
High: Give insulin
Low: Give potassium first, then give insulin
o I: Insulin
Actaprapid short acting, continue until normal pH in and normal ketone, usually 12
hours
o D: Dextrose
o E: Embolism (heparin due to VTE risk)
o E: Eat nothing (NBM)
o R: Reason treat cause
Prognosis
Mortality rates
o 5-20% about 10x higher than DKA
o Significant mortality risk in people aged >70
Complications
Life-threatening: VTE, confusion, DIC, MI, PE, cerebral oedema, coma, stroke
Treatment-related: Hypoglycaemia, hypokalaemia
DKA HHS